Washington – The US Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives. Therapies For Many Types of Diseases and Conditions In 2023, CDER approved 55 novel drugs, as detailed in our annual New Drug Therapy Approvals report. The …
Washington – The US Food and Drug Administration (FDA) approved Biogen BIIB.O and Sage Therapeutics’ SAGE.O oral pill to treat postpartum depression (PPD) in adults. The companies had sought the FDA’s approval for the drug, Zurzuvae, to treat major depressive disorderdrug, Zurzuvae, to treat major depressive disorder (MDD), or clinical depression, as well as postpartum depression, which affect millions of …
